CHTN BIBLIOGRAPHY 1987- FEB 2019 Abstracts and meeting presentations are not included in this bibliography. PMCIDs are indicated where available. If unavailable at the time of update they are marked UA. Since 2001, the bibliography has been generated by electronic searches that identify the CHTN as a source of human tissues used in the research together with the results of surveys carried out by Divisions when and if these were provided to Dr. Hunter. It should be noted most investigators who respond to the surveys or contact the CHTN regarding publication also credit the CHTN in the publication. The publications record cannot be analyzed reliably as a function of time. For example, the Coordinating Committee of the CHTN decided that publications by the principal investigators of the CHTN should be included for the last grant period (2012-2019), whether or not they mentioned the CHTN. From 1987 to 2012, publications by the Principal Investigators and CHTN personnel were not included unless the reported research utilized tissues supplied by the CHTN or pertained to Tissue Banking. The publications record for 2012-2019 includes searches for Tissue Microarrays prepared/distributed by the Midwestern Division. The publications record for 2012-2019 does not include all publications from the Children’s Oncology Group. The Pediatrics Division should indicate if any such publications should be included in the overall CHTN Bibliography. From 1997 to 2001, the bibliography was prepared by a company who used a strategy in which a list of all publications by investigators who used CHTN tissues was generated. The company assumed that they could the query the investigators to select the relevant publications. However, this process broke down due, in part, to a low response rate from investigators and the labor involved in follow-up. Issues in follow-up included the considerable lag time between provision of tissue and publication of the data (that is, the shipping data for any one year does not align with the publication record for that or several previous years). The bibliography was culled to remove publications that did not utilize human tissues or where the source of human tissues was provided in the publication and the CHTN was not included but the accuracy of this portion of the bibliography is questionable. From 1987 until 1997, the bibliography was based on self-reporting through surveys of the investigators who utilized tissues. As journals post full-length articles for this time period, searches have indicated some additional publications. 1 2019 (Partial Year through Feb) 29 publications 1. Bahreini F, Soltanian AR: Identification of A Gene Set Associated with Colorectal Cancer in Microarray Data Using The Entropy Method. Cell J. 2019. 20:569-575. PMID: 30124005. PMC PMC6099136 2. Bashir B, Merlino DJ, Rappaport JA, Gnass E, Palazzo JP, Feng Y, Fearon ER, Snook AE, Waldman SA: Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated and MSI colorectal neoplasia. Hum Pathol. 2019. PMID: 30716341. PMC UA 3. Baumann B, Acosta AM, Richards Z, Deaton R, Sapatynska A, Murphy A, Kajdacsy- Balla A, Gann PH, Nonn L: High miR-182 Levels Associate with Low-Risk Prostate Cancer. Am J Pathol. 2019. PMID: 30703341. PMC PMCUA 4. Chung J, Karkhanis V, Baiocchi RA, Sif S: Protein Arginine Methyltransferase 5 (PRMT5) Promotes Survival of Lymphoma Cells via Activation of WNT/beta-CATENIN and AKT/GSK3beta Proliferative Signaling. J Biol Chem. 2019. PMID: 30885941. PMC UA 5. Coburn LA, Singh K, Asim M, Barry DP, Allaman MM, Al-Greene NT, Hardbower DM, Polosukhina D, Williams CS, Delgado AG, Piazuelo MB, Washington MK, Gobert AP, Wilson KT: Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis. Oncogene. 2019. 38:1067-1079. PMID: 30202097. PMC PMC6377304 6. Cornett A, Athwal HK, Hill E, Murphy G, 3rd, Yeoh K, Moskaluk CA, Witt RL, D'Silva NJ, Agarwal S, Lombaert IMA: Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation. EBioMedicine. 2019. PMID: 30765319. PMC UA 7. Deng H, Mondal S, Sur S, Woodworth CD: Establishment and optimization of epithelial cell cultures from human ectocervix, transformation zone, and endocervix optimization of epithelial cell cultures. J Cell Physiol. 2019. PMID: 30609028. PMC UA 8. Farran B, Albayrak S, Abrams J, Tainsky MA, Levin NK, Morris R, Matherly LH, Ratnam M, Winer I: Serum folate receptor alpha (sFR) in ovarian cancer diagnosis and surveillance. Cancer Med. 2019. PMID: 30761774. PMC UA 9. Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM: Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019. PMID: 30617194. PMC UA 10. John B, Naczki C, Patel C, Ghoneum A, Qasem S, Salih Z, Said N: Regulation of the bi- directional cross-talk between ovarian cancer cells and adipocytes by SPARC. Oncogene. 2019. PMID: 30765860. PMC UA 11. Kumar P, Marinelarena A, Raghunathan D, Ragothaman VK, Saini S, Bhattacharya P, Fan J, Epstein AL, Maker AV, Prabhakar BS: Critical role of OX40 signaling in the TCR- independent phase of human and murine thymic Treg generation. Cell Mol Immunol. 2019. 16:138-153. PMID: 29578532. PMC PMC6355936 12. Liu Y, Pandey PR, Sharma S, Xing F, Wu K, Chittiboyina A, Wu SY, Tyagi A, Watabe K: ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness. Breast Cancer Res Treat. 2019. PMID: 30725231. PMC UA 2 13. Locke LW, Crouser ED, White P, Julian MW, Caceres EG, Papp AC, Le VT, Sadee W, Schlesinger LS: IL-13-regulated Macrophage Polarization during Granuloma Formation in an In Vitro Human Sarcoidosis Model. Am J Respir Cell Mol Biol. 2019. 60:84-95. PMID: 30134122. PMC PMC6348723 14. Lu C, Yang D, Klement JD, Oh IK, Savage NM, Waller JL, Colby AH, Grinstaff MW, Oberlies NH, Pearce CJ, Xie Z, Kulp SK, Coss CC, Phelps MA, Albers T, Lebedyeva IO, Liu K: SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion. Cancer Immunol Res. 2019. PMID: 30610059. PMC UA 15. Maseda D, Zackular JP, Trindade B, Kirk L, Roxas JL, Rogers LM, Washington MK, Du L, Koyama T, Viswanathan VK, Vedantam G, Schloss PD, Crofford LJ, Skaar EP, Aronoff DM: Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response. MBio. 2019. 10:PMID: 30622186. PMC PMC6325247 16. Mir H, Kaur G, Kapur N, Bae S, Lillard JW, Jr., Singh S: Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation. Sci Rep. 2019. 9:2527. PMID: 30792527. PMC PMC6385302 17. Mohanty S, Yerneni K, Theruvath JL, Graef CM, Nejadnik H, Lenkov O, Pisani L, Rosenberg J, Mitra S, Cordero AS, Cheshier S, Daldrup-Link HE: Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death Dis. 2019. 10:36. PMID: 30674867. PMC PMC6367456 18. Nam HY, Chandrashekar DS, Kundu A, Shelar S, Kho EY, Sonpavde G, Naik G, Ghatalia P, Livi CB, Varambally S, Sudarshan S: Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Mol Cancer Res. 2019. 17:84-96. PMID: 30131446. PMC UA 19. Nikhil K, Chang L, Viccaro K, Jacobsen M, McGuire C, Satapathy SR, Tandiary M, Broman MM, Cresswell G, He YJ, Sandusky GE, Ratliff TL, Chowdhury D, Shah K: Identification of LIMK2 as a Therapeutic Target in Castration Resistant Prostate Cancer. Cancer Lett. 2019. PMID: 30716360. PMC UA 20. Nixon BR, Sebag SC, Glennon MS, Hall EJ, Kounlavong ES, Freeman ML, Becker JR: Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response. FASEB J. 2019. 33:1138-1150. PMID: 30106602. PMC PMC6355065 21. Sans M, Zhang J, Lin JQ, Feider CL, Giese N, Breen MT, Sebastian K, Liu J, Sood AK, Eberlin LS: Performance of the MasSpec Pen for Rapid Diagnosis of Ovarian Cancer. Clin Chem. 2019. PMID: 30770374. PMC UA 22. Short SP, Thompson JJ, Bilotta AJ, Chen X, Revetta FL, Washington MK, Williams CS: Serine Threonine Kinase 17A maintains the epithelial state in colorectal cancer cells. Mol Cancer Res. 2019. PMID: 30655319. PMC UA 23. Smalley T, Islam SMA, Apostolatos C, Apostolatos A, Acevedo-Duncan M: Analysis of PKC-zeta protein levels in normal and malignant breast tissue subtypes. Oncol Lett. 2019. 17:1537-1546. PMID: 30675210. PMC PMC6341665 24. Somasundaram DB, Aravindan S, Yu Z, Jayaraman M, Tran NTB, Li S, Herman TS, Aravindan N: Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples. BMC Cancer. 2019. 19:106. PMID: 30691436. PMC PMC6348625 25. Song SJ, Shafique K, Wong LQ, LiVolsi VA, Montone KT, Baloch Z: The utility of the Milan System as a risk stratification tool for salivary gland fine needle aspiration cytology specimens. Cytopathology. 2019. 30:91-98. PMID: 30303566. PMC UA 26. Spino M, Kurz SC, Chiriboga L, Serrano J, Zeck B, Sen N, Patel S, Shen G, Vasudevaraja V, Tsirigos A, Suryadevara CM, Frenster JD, Tateishi K, Wakimoto H, Jain R, Riina HA, Nicolaides TP, Sulman EP, Cahill DP, Golfinos JG, Isse K, Saunders LR, Zagzag D, Placantonakis DG, Snuderl M, Chi AS: Cell Surface Notch Ligand DLL3 is a Therapeutic Target 3 in Isocitrate Dehydrogenase-mutant Glioma.